Back to Search
VINCENT HO, MD
MD
Medical Oncology Physician
NPI: 1245207737IndividualAccepts Medicare
Education
HARVARD MEDICAL SCHOOL
Class of 1996
Research & Publications (20)
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
PMID 19539216·Biol Blood Marrow Transplant·2009
3-trial
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.
PMID 17994121·Bone Marrow Transplant·2008
6-review
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: review and update on the use of defibrotide.
PMID 17525895·Semin Thromb Hemost·2007
6-review
HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation.
PMID 16532020·Bone Marrow Transplant·2006
4-observational
Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.
PMID 16041306·Biol Blood Marrow Transplant·2005
6-review
Post-transplant hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.
PMID 16029969·Rev Clin Exp Hematol·2004
6-review
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease.
PMID 15489873·Bone Marrow Transplant·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST
BOSTON, MA 02115 - Phone
- (617) 632-5938
Quick Facts
- NPI
- 1245207737
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile